KZA 0.00% 8.0¢ kazia therapeutics limited

Effects of PI3K Inhibition on Peripheral Leukocytes in Metastatic Breast Cancer, page-11

  1. 1,161 Posts.
    lightbulb Created with Sketch. 859
    Absolutely, high possibility of Cantrixil deal before Kazia's AGM, especially after management's comments in the 2020 Annual Report.

    Looking forward to confirmation of the first patient recruitment in the GBM AGILE study for Paxalisib. and the next 200 patients over the following 12 months.

    Looking forward to the first interim data next year from the ALLIANCE study for Paxalisib.

    Regards.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.